Emeren Group (SOL) Proxy Filing summary

Executive summary

• Shareholders are asked to vote on a merger agreement under which the company will be acquired and taken private by affiliates of its chairman and largest shareholder, with certain management and investor shares rolled over into the new parent entity.

• The merger consideration is $0.20 per ordinary share or $2.00 per ADS, representing a 68.1% premium to the unaffected ADS price as of March 14, 2025.

• The Special Committee of independent directors, with its own legal and financial advisors, unanimously recommended the merger as fair and in the best interests of unaffiliated shareholders.

• An independent financial advisor (Duff & Phelps/Kroll) opined that the merger consideration is fair from a financial point of view to unaffiliated shareholders.

• If approved, the company will be delisted from the NYSE and cease to be a public reporting company.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) approval of the merger agreement, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) a proposal to adjourn the meeting if more time is needed to solicit votes.

• Approval of the merger requires a majority of shares present and voting; the buyer group and supporting holders control about 39.6% of the voting power.

• Dissenting shareholders may seek appraisal rights under BVI law; ADS holders must convert to ordinary shares to exercise these rights.

Board of directors and corporate governance

• The Special Committee comprised three independent, unaffiliated directors with no financial interest in the merger beyond ordinary compensation.

• The board, with the chairman recused, unanimously approved the merger and recommends shareholders vote in favor.

• The board and Special Committee considered alternatives, including a competing proposal, but determined the merger was the best available option.